BNP PARIBAS FINANCIAL MARKETS - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 91 filers reported holding GLYCOMIMETICS INC in Q4 2020. The put-call ratio across all filers is 7.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q3 2023$722
-13.7%
4810.0%0.00%
Q2 2023$837
+38.1%
4810.0%0.00%
Q1 2023$606
-58.4%
4810.0%0.00%
Q4 2022$1,457
-99.5%
4810.0%0.00%
Q3 2022$265,000
-8.0%
4810.0%0.00%
Q2 2022$288,000
-47.4%
4810.0%0.00%
Q1 2022$548,000
-20.9%
4810.0%0.00%
Q4 2021$693,000
-41.6%
481
-11.3%
0.00%
Q3 2021$1,187,000
-5.6%
5420.0%0.00%
Q2 2021$1,257,000
-97.2%
542
-96.4%
0.00%
Q1 2021$45,364,000
+71.0%
15,071
+113.6%
0.00%
Q4 2020$26,534,000
+1.0%
7,057
-17.5%
0.00%
Q3 2020$26,270,000
+282.4%
8,557
+368.4%
0.00%
Q2 2020$6,870,000
-71.2%
1,827
-82.5%
0.00%
Q1 2020$23,867,000
+14.0%
10,468
+164.5%
0.00%
Q4 2019$20,933,000
-10.9%
3,957
-27.4%
0.00%
Q3 2019$23,502,000
-48.2%
5,453
+43.3%
0.00%
Q2 2019$45,368,000
-48.6%
3,806
-46.3%
0.00%
Q1 2019$88,341,000
+458.2%
7,090
+545.1%
0.00%
Q3 2018$15,826,000
-10.7%
1,0990.0%0.00%
Q2 2018$17,727,000
+1660.4%
1,099
+1426.4%
0.00%
Q3 2017$1,007,000
+25.2%
720.0%0.00%
Q2 2017$804,000
-85.0%
72
-90.4%
0.00%
Q3 2016$5,370,000
+82.4%
751
+85.4%
0.00%
Q2 2016$2,944,000
+126.8%
405
+116.6%
0.00%
Q3 2014$1,298,000
-73.9%
187
-68.3%
0.00%
Q2 2014$4,965,0005890.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 9,544,262$35,886,0001.41%
NEA Management Company, LLC 9,089,041$34,175,0000.90%
Camber Capital Management LP 2,200,000$8,272,0000.29%
HITE Hedge Asset Management LLC 78,621$296,0000.07%
PRENTISS SMITH & CO INC 14,000$53,0000.02%
Marquette Asset Management, LLC 23,403$88,0000.02%
CAAS CAPITAL MANAGEMENT LP 500,225$1,881,0000.02%
ClariVest Asset Management LLC 130,000$489,0000.02%
Jump Financial, LLC 26,200$99,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 205,200$772,0000.02%
View complete list of GLYCOMIMETICS INC shareholders